TRANEXAMIC ACID FOR THE TREATMENT OF POSTPARTUM HAEMORRHAGE: AN INTERNATIONAL RANDOMISED, DOUBLE BLIND, PLACEBO CONTROLLED TRIA
- Conditions
- -O72O72
- Registration Number
- PER-099-10
- Lead Sponsor
- ONDON SCHOOL OF HYGIENE & TROPICAL MEDICINE,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 0
• All legally adult women with a medical diagnosis of postpartum hemorrhage after a vaginal or cesarean delivery; the women have been able to give birth in the participating hospital or outside it, and have been admitted after childbirth
• The medical diagnosis of PPH may be based on the following: estimated blood loss after vaginal delivery> 500 ml, loss of> 1,000 ml after cesarean delivery, estimated estimated blood loss to endanger the hemodynamic state of the woman
• Women for whom the responsible physician considers that there is a clear indication for the use of ATX should not participate in the assignment.
• Women for whom the responsible physician considers that there is a clear contraindication for the use of ATX should not participate in the assignment (for example, having suffered a thromboembolic event during pregnancy).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <br>Outcome name:Number of women who die or undergo a hysterectomy. The leading cause of death will be described.<br>Measure:Proportion of women who die or undergo a hysterectomy<br>Timepoints:42 days<br>
- Secondary Outcome Measures
Name Time Method